What drives a normal relation between T-CD4 and T-CD8? by R Badura et al.
POSTER PRESENTATION Open Access
What drives a normal relation between T-CD4
and T-CD8?
R Badura1*, RJG Antunes2, N Janeiro1, C Afonso1, F Antunes3
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Introduction
Inversion of the CD4/CD8 ratio, in the context of HIV
infection, is a frequent finding, even though, if the
patient has been on prolonged antiretroviral therapy.
Nonetheless, in a small proportion undergoing antiretro-
viral therapy, this relation normalizes.
Purpose of the study
With the aim to investigate frequency and the popula-
tion characteristics of this occurrence we proposed a
retrospective analysis in our outpatient HIV clinic in
Lisbon.
Methods
Patients with a proven inversion of CD4/CD8 ratio
before the beginning of antiretroviral treatment and
who, in the last five years, re-inverted to a normalized
ratio (above one) in at least two consecutive estimations
were eligible. Variables analyzed included: gender, age,
former opportunistic infections, CD4+ nadir, viral load,
length of antiretroviral therapy and therapeutic regime.
Obtained data was tested for correlation and statistical
significance using student T-test.
Results
Of 1.750 patients on antiretroviral therapy, 119 patients
reverted to a normal T-CD4/CD8 ratio in the last five
years. Six of these where infected with HIV-2, five did
not maintain reversion, which lead to a 108 patients
with a true reversion, corresponding to 6% of the popu-
lation. Not being able to access the files in 18 cases, the
analysis is based on 90 patients. The mean-time of anti-
retroviral therapy before reversion of the CD4/CD8 ratio
was 69 month. The distribution reveals two peaks: one
around month 40th and another around month 130th,
probably related to former therapeutic regimes. No sig-
nificant correlation was found if time-of-antiretroviral-
therapy-until-reversion was analysed with respect to
impact by opportunistic infection, T-CD4 nadir, viral
load, gender or the ability of the antiretroviral therapy
to penetrate the CNS. Though, not a frequent finding, it
seems to be constant and strongly correlated to time-of-
antiretroviral-therapy with a correlation of Pearson of
0,501 (p=0.01).
Conclusions
These findings suggest that the CD4/CD8 might be a
marker for the follow-up in patient undergoing antire-
troviral therapy. Its real impact, though, needs further
investigation especially with respect to T-CD8 specific
cytotoxicity and activation.
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